🔎 Trials Near Me

Почетна › Рак плућа › Пенсилванија

Kliničke studije za Рак плућа u državi Пенсилванија

57 studija za Рак плућа traži učesnike na lokacijama u državi Пенсилванија.

Gradovi u državi Пенсилванија

Zvanični tekst studije (na engleskom)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  • Alliance Cancer Specialists - Media, Media
  • Guthrie Medical Group, Sayre
Тражи се учесникФаза 3
Узраст од 18 до 100 · Оба пола · Ажурирано 13. 11. 2026. · NCT05920356

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

  • Hospital of the University of Pennsylvania, Philadelphia
  • West Penn Allegheny Health, Pittsburgh
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07100080

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Bryn Mawr Hospital, Bryn Mawr
  • и још 14
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • UPMC Altoona, Altoona
  • UPMC-Heritage Valley Health System Beaver, Beaver
  • и још 52
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

  • Clinical Research Associates of Central Pennsylvania, DuBois
Тражи се учесник
Узраст од 50 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT07168993

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Bryn Mawr Hospital, Bryn Mawr
  • Penn State Milton S Hershey Medical Center, Hershey
  • Riddle Memorial Hospital, Media
  • и још 6
Тражи се учесникФаза 3
Узраст 70 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06096844

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  • Sidney Kimmel Cancer Center, Philadelphia
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07458347

Detection of Genetic Markers of Lung Cancer

  • Hillman Cancer Center, Pittsburgh
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT00280202

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07020221

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Penn State Milton S. Hershey Medical Center-Penn State Cancer Institute ( Site 0059), Hershey
  • Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06312137

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Lehigh Valley Health Network, Allentown
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT04198766

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  • St. Luke's University Health Network, Bethlehem
  • Allegheny Cancer Center, Pittsburgh
  • Reading Hospital - McGlinn Cancer Institute, West Reading
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06793215

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Geisinger Medical Center, Danville
  • и још 7
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Bryn Mawr Hospital, Bryn Mawr
  • и још 12
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT04181060

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Cancer Care Associates of York (site 206), York
Тражи се учесникФаза 1/2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT03556228

Distance-Based Exercise to Preserve Function and Prevent Disability

  • UPMC Hillman Cancer Center at Butler Health System, Butler
  • UPMC Hillman Cancer Center - Passavant - Cranberry, Cranberry Township
  • IRMC Cancer Center, Indiana
  • и још 6
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07059884

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • USO - Alliance Cancer Specialists, PC, Horsham
  • Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

  • Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06060613

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  • Fox Chase Cancer Center, Philadelphia
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07185997

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

  • Hospital of the University of Pennsylvania, Philadelphia
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07499674

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

  • UPMC Hillman Cancer Center, Pittsburgh
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06287775

Lung Cancer Detection in Never Smokers Using Urine Volatile Organic Compound (VOCs)

  • Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07871656

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

  • Research Site, Pittsburgh
Тражи се учесникФаза 2
Узраст од 18 до 95 · Оба пола · Ажурирано 21. 10. 2026. · NCT05061550

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

  • University of Pennsylvania, Philadelphia
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06244771

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • UPMC Hillman Cancer Center, Pittsburgh
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06162221

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  • Avenzo Therapeutics Recruiting Site, Philadelphia
Тражи се учесникФаза 1/2
Узраст од 18 до 75 · Оба пола · Ажурирано 16. 10. 2026. · NCT07038343

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

  • Abramson Cancer Center ( Site 0010), Philadelphia
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06731907

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • St. Luke's Physician Group - St. Luke's Cancer Care Associates, Fountain Hill
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06712355

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • WellSpan Medical Oncology and Hematology, Chambersburg
  • Geisinger Medical Center, Danville
  • Geisinger Cancer Center Dickson City, Dickson City
  • и још 10
Тражи се учесникФаза 2
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • UPMC-Heritage Valley Health System Beaver, Beaver
  • UPMC Hillman Cancer Center at Butler Health System, Butler
  • WellSpan Medical Oncology and Hematology, Chambersburg
  • и још 31
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Empathic Communication Skills (ECS) Training

  • University of Pennsylvania (Data Collection Only), Philadelphia
  • Fox Chase Cancer Center (Data Collection Only), Philadelphia
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 100 · Оба пола · Ажурирано 7. 10. 2026. · NCT05456841

MOv19-BBz CAR T Cells in FRa+ Cancers

  • University of Pennsylvania, Philadelphia
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07116057

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
  • University of Pittsburgh Medical Center, Pittsburgh
  • WellSpan York Cancer Center, York
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Alliance Cancer Specialists, Sellersville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT06765109

A Registry for People With Lung Cancer

  • Thomas Jefferson University Hospital (Data Collection Only), Philadelphia
  • ALLEGHENY HEALTH NETWORK (Data Collection Only), Pittsburgh
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT06424327

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Allegheny Health Network, Pittsburgh
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT06128551

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

  • UPMC Hillman Cancer Center, Pittsburgh
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 4. 9. 2026. · NCT07012031

Pemefolacianine for IMI of Lung Cancer

  • University of Pennsylvania, Philadelphia
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT07772895

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Christiana Care Health System-Concord Health Center, Chadds Ford
  • Chambersburg Hospital, Chambersburg
  • Geisinger Medical Center, Danville
  • и још 17
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT05624996

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

  • UPMC Hillman Cancer Center, Pittsburgh
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 7. 2026. · NCT07315113

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.